COVID-19 & CancerFreeGuest Editorial When disparities widen: COVID-19 in minority patients with cancer April 24, 2020Vol.46 No.17By Coral Olazagasti and Narjust Florez
COVID-19 & CancerFreeGuest Editorial Cancer care continues during COVID-19 pandemic—with new tools and old challenges April 17, 2020Vol.46 No.16By Ted Okon
COVID-19 & CancerFreeGuest Editorial Amid COVID-19 pandemic, cancer community responds to fill data gap April 17, 2020Vol.46 No.16By Richard L. Schilsky
COVID-19 & CancerFreeGuest Editorial Chernobyl doctor’s view of COVID-19: Trump threatens 267 years of progress in biomedical research April 10, 2020Vol.46 No.15By Robert Peter Gale
COVID-19 & CancerFreeGuest Editorial NCTN group chairs: Cancer trials take backseat to clinical care amid COVID-19 pandemic April 10, 2020Vol.46 No.15By Charles D. Blanke, Douglas S. Hawkins, Monica M. Bertagnolli, Peter J. O'Dwyer, Mitchell D. Schnall, Walter J. Curran, Norman Wolmark, Robert S. Mannel and Janet Dancey
FreeGuest Editorial What cancer immunologists are doing about COVID-19 April 03, 2020Vol.46 No.14By Rachel Humphrey
COVID-19 & CancerFreeGuest Editorial Friending viral foes: The Zika story and (perhaps) lessons for COVID-19 April 03, 2020Vol.46 No.14By Scott M. Lippman
COVID-19 & CancerFreeGuest Editorial The COVID-19 pandemic gives us the urgency—and one more chance—to address health disparities March 20, 2020Vol.46 No.12By Robert A. Winn
COVID-19 & CancerFreeGuest Editorial ASCO’s Response to COVID-19 March 18, 2020Vol.46 No.12By Richard L. Schilsky
COVID-19 & CancerFreeGuest Editorial COVID-19 and the cancer patient: A call to action for balancing cancer care and viral risk March 13, 2020Vol.46 No.11By Karen E. Knudsen and Roy A. Jensen
